Retractable Technologies, Inc. (NYSE:RVP) CEO Acquires $13,047.54 in Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw acquired 19,769 shares of the stock in a transaction dated Friday, June 13th. The stock was acquired at an average cost of $0.66 per share, with a total value of $13,047.54. Following the transaction, the chief executive officer now directly owns 15,418,986 shares in the company, valued at approximately $10,176,530.76. This represents a 0.13% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Retractable Technologies Stock Performance

Shares of NYSE:RVP traded up $0.03 during trading on Monday, reaching $0.68. The company had a trading volume of 23,833 shares, compared to its average volume of 69,074. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92. Retractable Technologies, Inc. has a fifty-two week low of $0.56 and a fifty-two week high of $1.21. The firm has a market capitalization of $20.24 million, a price-to-earnings ratio of -1.25 and a beta of 1.39. The stock’s fifty day moving average price is $0.70 and its 200 day moving average price is $0.72.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Retractable Technologies stock. Renaissance Technologies LLC raised its position in Retractable Technologies, Inc. (NYSE:RVP) by 9.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 361,253 shares of the company’s stock after purchasing an additional 31,140 shares during the quarter. Renaissance Technologies LLC owned about 1.21% of Retractable Technologies worth $249,000 as of its most recent filing with the Securities and Exchange Commission. 7.58% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Wall Street Zen started coverage on Retractable Technologies in a research report on Thursday, May 22nd. They issued a “hold” rating on the stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.